All PlansDocumentationHigh impact
Lumbar Fusion 7.01.117
Excellus BlueCross BlueShield·NY · Orthopedics, Neurosurgery, Pain Management·Bone & Joints (Orthopedic)
Effective date
Mar 1, 2026
We identified it
Jul 16, 2026
Summary
Excellus BlueCross BlueShield has updated the Lumbar Fusion policy (07.01.117) effective March 1, 2026, establishing comprehensive medical necessity criteria across six indications with decompression and two without decompression. A critical new requirement mandates documentation of nicotine-free status (never smoker OR cotinine <10ng/mL within 6 weeks) for ALL lumbar fusion cases, which will significantly impact pre-authorization and claim adjudication workflows.
Action Required
By February 15, 2026: (1) Billing team must update prior authorization templates and checklists to REQUIRE documentation of nicotine-free status for all lumbar fusion requests—specifically blood cotinine lab results (<10ng/mL) or attestation of never-smoker status. (2) Providers must add nicotine status verification to all pre-op requirements and EMR templates. (3) Update claim scrubbing logic to flag missing nicotine documentation as a denial risk. (4) Train front-desk and authorization staff that claims lacking cotinine labs or smoking status documentation will be denied. (5) Create patient education materials explaining 6-week cessation requirement before surgery date. (6) Modify denial letter templates to cite missing nicotine-free documentation as specific denial reason. Claims submitted without documented nicotine-free status will be denied regardless of other medical necessity criteria being met.